Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Acute Myeloid Leukemia

Reassessing autotransplantation for acute myeloid leukaemia in first remission – a matched pair analysis of autologous marrow vs peripheral blood stem cells

Bone Marrow Transplantation volume 33, pages 1209–1214 (2004)Cite this article

Summary:

The role of autologous stem cell transplantation in adult patients with acute myeloid leukaemia (AML) in first remission is unclear, yet it has become standard treatment for myeloma and this paper explores whether the source of transplanted stem cells may explain this paradox. In total, 57 patients from the Royal Marsden Hospital who received an unpurged bone marrow transplant (ABMT) were matched with 114 patients from the EBMT registry who had undergone peripheral blood stem cell transplantation (PBSCT). Patients were matched for karyotype, FAB type, remission-autograft interval and age. In the PBSCT group, haematopoietic recovery was significantly faster and nonrelapse mortality at 4 years was significantly lower (13 vs 1%, P=0.04). The relapse rate and overall survival at 4 years (20 vs 31% and 77 vs 63%) were also better with PBSCT, although the differences were not statistically significant. Autografting should be reassessed in a randomised trial for first remission AML patients using peripheral blood as a source of stem cells rather than bone marrow.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Burnett AK . Transplantation in first remission of acute myeloid leukemia. N Engl J Med 1998; 339: 1698–1700.

    Article  CAS  PubMed  Google Scholar 

  2. Cassileth PA, Harrington DP, Appelbaum FR et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 1998; 339: 1649–1656.

    Article  CAS  PubMed  Google Scholar 

  3. Burnett AK, Goldstone AH, Stevens RMF et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. Lancet 1998; 351: 700–708.

    Article  CAS  PubMed  Google Scholar 

  4. Child JA, Morgan GJ, Davies FE et al. High-dose chemotherapy with haematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875–1883.

    Article  CAS  PubMed  Google Scholar 

  5. Raje N, Powles R, Kulkarni S et al. A comparison of vincristine, doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma. Br J Haematol 1997; 97: 153–160.

    Article  CAS  PubMed  Google Scholar 

  6. Mehta J, Powles R, Horton C et al. Factors affecting engraftment and hematopoietic recovery after unpurged autografting in acute leukemia. Bone Marrow Transplant 1996; 18: 319–324.

    CAS  PubMed  Google Scholar 

  7. Mehta J, Powles R, Singhal S et al. Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukaemia due to reinfusion of a higher number of malignant cells. Bone Marrow Transplant 1995; 15: 652–653.

    CAS  PubMed  Google Scholar 

  8. Reiffers J, Labopin M, Sanz M et al. Autologous blood cell vs marrow transplantation for acute myeloid leukaemia in complete remission: an EBMT retrospective analysis. Bone Marrow Transplant 2000; 25: 1115–1119.

    Article  CAS  PubMed  Google Scholar 

  9. de Witte T, Keating S, Suciu S et al. A randomized comparison of the value of autologous BMT versus autologous PSCT for patients with AML in first CR in the AML 10 Trial of the EORTC LCG and GIMEMA. Blood 2001; 98: 859a.

    Article  Google Scholar 

  10. Mehta J, Powles R, Treleaven J et al. The impact of karyotyping on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy. Leuk Lymphoma 1999; 34: 553–560.

    Article  CAS  PubMed  Google Scholar 

  11. Powles R, Milan S, Horton C et al. The Royal Marsden Hospital leukaemia–myeloma database: an ‘Operations Research’ resource for assessing clinical outcomes and planning new drug trials. Blood 2001; 98: 426a.

    Google Scholar 

  12. Wheatley K, Burnett AK, Goldstone AH et al. A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. Br J Haematol 1999; 107: 69–79.

    Article  CAS  PubMed  Google Scholar 

  13. Mehta J, Powles R, Singhal S et al. Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors. Bone Marrow Transplant 1995; 16: 499–506.

    CAS  PubMed  Google Scholar 

  14. Kruskal WH, Wallis WA . Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952; 47: 583–621.

    Article  Google Scholar 

  15. Kaplan EL, Meier P . Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.

    Article  Google Scholar 

  16. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia, The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995; 332: 217–223.

    Article  CAS  PubMed  Google Scholar 

  18. Harousseau JL, Cahn JY, Pignon B et al. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukaemia. Blood 1997; 90: 2978–2986.

    CAS  PubMed  Google Scholar 

  19. Gorin NC, Aegerter P, Auvert B et al. Autologous bone marrow transplantation for acute myelocytic leukaemia in first remission: a European survey of the role of marrow purging. Blood 1990; 75: 1606–1614.

    CAS  PubMed  Google Scholar 

  20. Gorin NC . Autologous stem cell transplantation for adult acute leukaemia. Curr Opin Oncol 2002; 14: 152–159.

    Article  PubMed  Google Scholar 

  21. Gorin NC, Labopin M . Treatment of acute myeloid leukaemia. N Engl J Med 1999; 340: 1437 (letter).

    CAS  PubMed  Google Scholar 

  22. Powles R, Sirohi B, Treleaven J et al. The role of post-transplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukaemia. Blood 2002; 100: 1641–1647.

    Article  CAS  PubMed  Google Scholar 

  23. Powles R, Sirohi B, Mehta J et al. Reduced relapse rates in newly-treated myeloma patients by using peripheral blood stem cells over bone marrow as the source of stem cells for autologous transplantation: single-centre experience of 435 patients treated with 200 mg/m2 melphalan. Blood 2001; 98: 684a.

    Google Scholar 

  24. Lazarus HM, Rowlings PA, Zhang MJ et al. Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 1999; 17: 534–545.

    Article  CAS  PubMed  Google Scholar 

  25. Weaver CH, West W, Schwartzberg L et al. The rationale for performing autologous peripheralblood stem cell transplants in community cancer centers. Oncologist 1998; 3: 346–353.

    CAS  PubMed  Google Scholar 

  26. de Witte T, Brand R, van Biezen A et al. Peripheral stem cells are the preferred source of stem cells for autologous stem cell transplantation (ASCT) of young patients with MDS or AML following MDS: an analysis of the Chronic Leukaemia Working Party of the European Blood and Marrow Transplantation Group (EBMT). Blood 2001; 98: 848a.

    Article  Google Scholar 

  27. Thomas ED, Clift RA, Hersman J et al. Marrow transplantation for acute nonlymphoblastic leukaemia in first remission using fractionated or single-dose irradiation. Int J Rad Biol Phys 1981; 8: 817–821.

    Article  Google Scholar 

  28. Deeg HJ, Sullivan KM, Buckner CD et al. Marrow transplantation for acute nonlymphoblastic leukaemia in first remission: toxicity and long-term follow-up of patients conditioned with single-dose or fractionated total body irradiation. Bone Marrow Transplant 1986; 1: 151–157.

    CAS  PubMed  Google Scholar 

  29. Girinsky T, Benhamou E, Bourhis JH et al. Prospective randomised comparison of single-dose versus hyperfractionated total-body irradiation in patients with haematologic malignancies. J Clin Oncol 2000; 18: 981–986.

    Article  CAS  PubMed  Google Scholar 

  30. Powles R, Sirohi B, Treleaven J et al. Maximal response to infusional chemotherapy prior to autotransplantation influences outcome of patients with newly-diagnosed multiple myeloma. Blood 2000; 96: 292b.

    Google Scholar 

  31. Isnard F, Guiguet M, Laporte JP et al. Improved efficiency of remission induction facilitates autologous BMT harvesting and improves overall survival in adults with AML: 108 patients treated at a single institution. Bone Marrow Transplant 2001; 27: 1045–1052.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the David Adams Leukaemia Appeal Fund, Johnstone Britten Myeloma Fund, Jenny Bidwell Research Fund and the Bud Flanogan Leukaemia Fund.

Author information

Authors and Affiliations

  1. Royal Marsden Hospital and Institute of Cancer Research Surrey, UK

    B Sirohi, R Powles, C Rudin, S Singhal, S Vaidya, J Treleaven & C Horton

  2. European Blood and Bone Marrow Transplant Group, UK

    F Frassoni, A Bacigalupo, M Labopin, M Michallet, D Blaise, J Reiffers, G Meloni & B Rio

  3. Northwestern University, Chicago, USA

    J Mehta

Authors
  1. B Sirohi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Powles
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Kulkarni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Rudin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F Frassoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Bacigalupo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S Singhal
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S Vaidya
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Labopin
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M Michallet
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. D Blaise
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J Reiffers
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. G Meloni
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. B Rio
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. J Treleaven
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. C Horton
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. J Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R Powles.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sirohi, B., Powles, R., Kulkarni, S. et al. Reassessing autotransplantation for acute myeloid leukaemia in first remission – a matched pair analysis of autologous marrow vs peripheral blood stem cells. Bone Marrow Transplant 33, 1209–1214 (2004). https://doi.org/10.1038/sj.bmt.1704511

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704511

Keywords

This article is cited by

Search

Advanced search

Quick links